Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Catalytic activation of multimeric RNase E and RNase G by 5'-monophosphorylated RNAXunqing Jiang, Joel G BelascoMolecular Microbiology|November 8, 2002
Two distinct regions on the surface of an RNA-binding domain are crucial for RNase E functionAlexis A Diwa, Xunqing Jiang, Matthieu Schapira, et al.Vaccine|July 22, 2014
Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopesTimothy Cardozo, Shixia Wang, Xunqing Jiang, et al.Journal of Visualized Experiments : Jove|November 3, 2012
Skin tattooing as a novel approach for DNA vaccine deliveryYung-Nung Chiu, Jared M Sampson, Xunqing Jiang, et al.Nature Structural & Molecular Biology|July 13, 2010
Conserved structural elements in the V3 crown of HIV-1 gp120Xunqing Jiang, Valicia Burke, Maxim Totrov, et al.Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems|October 3, 2022
Mucosal Delivery of HIV-1 Glycoprotein Vaccine Candidate Enabled by Short Carbon NanotubesYang Xu, Xunqing Jiang, Ziyou Zhou, et al.Journal of Virology|July 29, 2011
Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNASusan Zolla-Pazner, X-P Kong, Xunqing Jiang, et al.Journal of Virology|October 7, 2016
Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in RabbitsXunqing Jiang, Max Totrov, Wei Li, et al.Journal of Virology|September 16, 2016
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody ResponseSusan Zolla-Pazner, Rebecca Powell, Sara Yahyaei, et al.Biochemical Engineering Journal|August 29, 2022
Engineered multivalent self-assembled binder protein against SARS-CoV-2 RBDDustin Britton, Kamia Punia, Farbod Mahmoudinobar, et al.Pageof 3